ArticlePediatric surgery international2026
Transfer learning prediction of 2-year native liver survival in biliary atresia following Kasai portoenterostomy using early perioperative biochemical data up to 3 months postoperatively.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundBiliary atresia (BA), a rare but life-threatening neonatal cholestatic disorder, necessitates Kasai portoenterostomy (KPE) as the primary surgical intervention. However, despite timely KPE within the recommended 60-day window, approximately 60% of infants ultimately require liver transplantation before age 2. Current prognostic tools lack the capacity to predict long-term native liver survival (NLS) using early perioperative biomarkers.
methodsThe study subjects were BA patients treated by a senior KPE surgeon at our center (93 cases) and another senior KPE surgeon at Jiangxi Children's Hospital (61 cases) from January 2017 to December 2022. Clinical and pathological follow-up data were collected. Five traditional machine learning (ML) algorithms (LRM, DET, MLP, SVC, RF) were trained on preoperative, intraoperative, and postoperative biomarkers up to 3 months post-KPE, encompassing biochemical profiles. The best-performing RF model was further enhanced using transfer learning (TL).
resultsFor a combined cohort of 154 patients, traditional statistical analysis revealed significant differences in perioperative factors between NLS and non-NLS groups, with multivariate logistic regression identifying surgical age (P = 0.029), globular proteins at 1 week postoperatively (GLO_1W, P < 0.001), aspartate aminotransferase at 1 month postoperatively (AST_1M, P = 0.007), albumin at 3 months postoperatively (ALB_3M, P = 0.029), gamma-glutamyl transpeptidase at 3 months postoperatively (GGT_3M, P < 0.001), direct bilirubin at 3 months postoperatively (DBIL_3M, P = 0.005), and prealbumin at 3 months postoperatively (PALB_3M, P = 0.004) as independent risk factors. The five traditional ML models showed varying performance, with RF demonstrating the highest average AUC in the training set (AUC = 0.795, 95% CI 0.709-0.881). The TL model, built on the RF base, achieved superior performance in the training set (AUC = 0.888, 95% CI 0.819-0.943) and validation set (AUC = 0.856, 95% CI 0.738-0.947). GGT_3M, ALB_3M, DBIL_3M, DBIL_1M and GLO_1W were identified as the most critical predictive features. A TL-based clinical decision support system was deployed, providing dynamic visualization of individualized 24-month NLS trajectories.
conclusionEarly perioperative biochemical data-driven ML models, enhanced by transfer learning, enable accurate prediction of 2-year NLS in BA. GGT_3M, ALB_3M, DBIL_3M, DBIL_1M, and GLO_1W are among the most influential predictors for 2-year NLS after KPE procedure.
Indexed as
Identifiers
42507013What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.